Marilyn Kwan to Hypertension
This is a "connection" page, showing publications Marilyn Kwan has written about Hypertension.
Connection Strength
1.023
-
Endocrine therapy adherence and 10-year cardiometabolic risk in hormone receptor-positive breast cancer. JNCI Cancer Spectr. 2026 Nov 02; 10(6).
Score: 0.704
-
A Mendelian Randomization Analysis of 55 Genetically Predicted Metabolic Traits with Breast Cancer Survival Outcomes in the Pathways Study. Cancer Res Commun. 2023 06; 3(6):1104-1112.
Score: 0.139
-
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Res Treat. 2023 Aug; 201(1):117-126.
Score: 0.139
-
Disparities in cardiometabolic and cardiovascular risk after breast cancer: the Pathways Heart Study. JNCI Cancer Spectr. 2026 Jan 09; 10(1).
Score: 0.042